Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
about
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesUnderstanding the regulation of Group B Streptococcal virulence factorsRecent advances in understanding the molecular basis of group B Streptococcus virulenceEmerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales, 1991-2010Challenges in reducing group B Streptococcus disease in African settings.Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillinCharacterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates.Prevalence of non-penicillin-susceptible group B streptococcus in Philadelphia and specificity of penicillin resistance screening methods.Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.Disease manifestations and pathogenic mechanisms of Group A Streptococcus.Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility.Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients.Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China.In vitro resistance to macrolides and clindamycin by Group B Streptococcus isolated from pregnant and nonpregnant women.Twenty Years of Active Bacterial Core SurveillanceEffect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance.Capsular serotype and antibiotic resistance of group B streptococci isolated from pregnant women in Ardabil, Iran.Culture and Real-Time PCR Based Maternal Screening and Antibiotic Susceptibility for Group B Streptococcus: An Iranian ExperienceGenetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.Survey of strain distribution and antibiotic resistance pattern of group B streptococci (Streptococcus agalactiae) isolated from clinical specimens.In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia.Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility.Treatment strategies for central nervous system infections.Early-onset neonatal sepsis.In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease.Fluoroquinolone Resistance among Clonal Complex 1 Group B Streptococcus Strains.High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility.Analysis of multidrug resistant group B streptococci with reduced penicillin susceptibility forming small, less hemolytic colonies.Development of a Novel Test for Simultaneous Bacterial Identification and Antibiotic Susceptibility.Reduced penicillin susceptibility of group B Streptococcus: an assessment of emergence in Grampian, Scotland.High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan.Asymptomatic group B streptococcal bacteriuria among pregnant women in Saudi Arabia.Molecular epidemiology of Streptococcus agalactiae recovered from significant bacteriuria.Associations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections.
P2860
Q28075884-C15DFB47-DFD8-445E-B07F-6AEA63D148FFQ28237019-E989B705-A58B-462E-A053-9E12F6FEFDEBQ28294474-0C950C7D-E779-4E4F-9986-C824F755723DQ30040402-BA4B7B46-BE6F-4CEC-B550-6823C62705DCQ30241490-B09E167F-F0E8-42EB-B021-3DC688F100D3Q33628628-50CDA2D9-D3B7-44A1-AA9C-8A6ECDF4DFD3Q33676380-EAF67E16-07C9-41DB-BC14-0B57F265D16CQ33703629-AB96EF71-B313-4E2E-A1D6-6904CAB2DA4BQ33769459-485ED180-A8AE-4043-A7AC-C012E8A2A193Q33771867-59DBB423-5F1F-47AF-9B41-E5C75B95D467Q34413457-55678F9F-EC56-4171-9062-1978FD34F5FBQ34433251-CD171E0A-81E8-4EB1-8096-5830F7BA28F4Q35004841-2F2C3E44-0934-4CEE-823A-90DA12B33B34Q35035805-636C5D91-04A9-4100-8DEA-C1CA562BFC9AQ35169242-8183D9E8-EDB3-4B1A-B938-942CA8CE5297Q35188390-C9447724-13FC-42DE-8B53-71BC70780ABCQ35996618-86B2A614-DD6E-4F04-B4BE-4C8C134E77A7Q35997450-A864580C-8B07-49A7-978C-867BA3ACAF0BQ35997535-BF3CF46A-E9A0-4343-A84A-017C918F3EB5Q36301229-675E6B0C-A30B-4287-8997-54B74EC2A9C7Q36718067-7D752B73-1FE8-4E59-91AC-634685239E39Q36993479-14B0DB62-3B73-4D0D-9235-4CB95ABE62BBQ37254222-B9CEDBF3-4EC1-4A43-9148-ED89263C5F8CQ37335777-A6B75A8C-D810-447F-89AD-537798C77E68Q37363399-C0D82297-97B4-46D0-9B69-77446175EA34Q37451778-31626E73-F069-4B58-89C6-124F6D517EC2Q37483938-92FA3F77-39A8-42F5-B7C3-6019C335EAEFQ37544901-84C72E7D-FEEC-485A-9E26-11605016C2B8Q37643673-C2DAEC9F-48D5-44A0-B931-77B29B60423EQ38570903-F6779163-135C-482D-B450-862F0A7D593BQ38844623-64509118-8A71-44EB-9F03-34A9CF1D6BBDQ39455259-FDF8F08C-D9CE-46F5-A072-1F167A3A96D7Q39528009-96C6DB23-B952-4F1F-840D-B8AF783D89BAQ40089840-0D39C533-E67E-4F54-81B8-582A08753627Q40441455-48E5A3D1-D77C-40E0-AEEA-4590B5A6A1A4Q40673578-5F0BB44E-88DC-40EC-8A40-2A3CB149414CQ40743043-09D08EA2-D1A7-4BCA-B1FB-2A9ED503A5B8Q40934042-2721B8CB-6714-4CCD-9606-0E7515DA96EFQ41297811-512944F3-B325-4FFE-AC40-FEEFB8EDE40CQ42254586-150B62A7-EF44-490A-9691-62B73D0366ED
P2860
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Point mutation in the group B ...... ty to beta-lactam antibiotics.
@ast
Point mutation in the group B ...... ty to beta-lactam antibiotics.
@en
type
label
Point mutation in the group B ...... ty to beta-lactam antibiotics.
@ast
Point mutation in the group B ...... ty to beta-lactam antibiotics.
@en
prefLabel
Point mutation in the group B ...... ty to beta-lactam antibiotics.
@ast
Point mutation in the group B ...... ty to beta-lactam antibiotics.
@en
P2093
P2860
P356
P1476
Point mutation in the group B ...... ty to beta-lactam antibiotics.
@en
P2093
Bernard W Beall
Mary E Hensler
Robert E Gertz
Samira Dahesh
Stephanie Schrag
P2860
P304
P356
10.1128/AAC.00461-08
P407
P577
2008-06-09T00:00:00Z